Skip to main content

Day: July 28, 2025

Full Alliance Group Reports Second Quarter Preliminary results, Unveils Expansion into High-Growth Men’s Wellness Personal Care and Health Virility segment, Association Digital Benefits, and Expands its Contract Manufacturing Markets

TAMPA, Fla., July 28, 2025 (GLOBE NEWSWIRE) — Full Alliance Group, Inc. (OTC: FAGI) today announced preliminary unaudited revenue results for the second quarter of 2025 and provided an exciting outlook for the remainder of the year, driven by strategic expansion into rapidly growing multi-billion-dollar markets including men’s wellness, telehealth benefits, and contract manufacturing. Q2 2025 Financial Highlights (Pro Forma) Total Revenue: Estimated Revenue in excess of $750,000 versus 2024 Q2 Revenue of $508,097 at least a 47% Year over year increase.The company expects continued growth into Q3 2025, with projected revenues estimated at well over $1 million dollars, driven by new product launches, newly launched affiliate revenue, new manufacturing agreements, and DTC subscription momentum.  Men’s Wellness Division...

Continue reading

FEMSA Announces Second Quarter 2025 Results

MONTERREY, Mexico, July 28, 2025 (GLOBE NEWSWIRE) — Fomento Económico Mexicano, S.A.B. de C.V. (“FEMSA”) (NYSE: FMX; BMV: FEMSAUBD, FEMSAUB) announced today its operational and financial results for the second quarter of 2025.FEMSA: Total Consolidated Revenues grew 6.3% and Income from Operations increased 1.2% compared to 2Q24. FEMSA Retail1: Proximity Americas total Revenues grew 6.9% and Income from operations decreased 2.8% versus 2Q24. SPIN: Spin by OXXO had 9.4 million active users2 representing 18.8% growth compared to 2Q24 while Spin Premia had 26.6 million active loyalty users2 representing 16.9% growth compared to 2Q24, and an average tender3 at OXXO Mexico of 45.8% which increased from 36.1% tender in 2Q24. COCA-COLA FEMSA: Total Revenues and Income from Operations grew 5.0% and 0.2%, respectively against 2Q24.Financial...

Continue reading

Varonis Introduces Next-Gen Database Activity Monitoring

New cloud-native DAM offering gives customers a simple, agentless solution to database security and compliance built for the AI era MIAMI, July 28, 2025 (GLOBE NEWSWIRE) — Varonis Systems, Inc. (Nasdaq: VRNS), the data security leader, today announced the release of Varonis Next-Gen Database Activity Monitoring (DAM), a groundbreaking new approach to database security that deploys quickly and overcomes the challenges legacy vendors face in preventing data breaches and ensuring regulatory compliance. Databases are the backbone of the global economy and serve as the central nervous system of AI, yet they’ve never been harder to protect. Lack of competition and complex barriers to entry have stifled innovation in the DAM market—until now. “Legacy DAM solutions like Imperva and IBM Guardium use outdated, agent-based technology that...

Continue reading

Form 8.3 – [MARLOWE PLC – 25 07 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree MARLOWE PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Oriental Rise Holding Limited Signs Non-Binding Letter of Intent to Acquire Daohe and Minji

Potential Strategic Acquisitions to Strengthen Vertical Integration and Expand Distribution Capabilities NINGDE, China, July 28, 2025 (GLOBE NEWSWIRE) — Oriental Rise Holdings Limited (“Oriental Rise” or the “Company”) (NASDAQ: ORIS), an integrated tea supplier in mainland China, today announced that it has entered into a non-binding letter of intent (“LOI”) to acquire 100 percent of the equity interests of Fujian Daohe Tea Technology Co., Ltd. (“Daohe”) and Ningde Minji Tea Co., Ltd. (“Minji,” and together with Daohe, the “Targets”), both leading tea distributors in China. The LOI marks a significant step in Oriental Rise’s strategy to expand and diversify its portfolio within China’s fast-growing consumer goods and wellness sectors. The Company will now begin comprehensive due diligence on the Targets and work toward negotiating...

Continue reading

YY Group Launches Robotics Integration to Boost Service Performance and Client Efficiency

Singapore, July 28, 2025 (GLOBE NEWSWIRE) — YY Group Holding Limited (NASDAQ: YYGH) (“YY Group,” “YYGH,” or the “Company”), a global leader in on-demand workforce solutions and integrated facility management (IFM), today announced the launch of a robotics integration initiative across its core service lines. The program is designed to enhance service delivery, strengthen workforce support, and help clients meet growing demands with greater consistency and efficiency Robotics Integration Across Key Sectors Phase one of the rollout focuses on high-impact areas where automation delivers immediate gains in service quality, speed, and reliability. In hospitality, robotic runners will support banquet teams by handling food delivery and event logistics, ensuring timely coordination during high-demand events. Autonomous cleaners will provide...

Continue reading

Citizens Community Bancorp, Inc. Reports Second Quarter 2025 Earnings of $0.33 Per Share; Board of Directors Authorize 5% Stock Buyback Authorization

EAU CLAIRE, Wis., July 28, 2025 (GLOBE NEWSWIRE) — Citizens Community Bancorp, Inc. (the “Company”) (Nasdaq: CZWI), the parent company of Citizens Community Federal N.A. (the “Bank” or “CCFBank”), today reported earnings of $3.3 million and earnings per diluted share of $0.33 for the second quarter ended June 30, 2025, compared to $3.2 million and earnings per diluted share of $0.32 for the quarter ended March 31, 2025, and $3.7 million and $0.35 earnings per diluted share for the quarter ended June 30, 2024, respectively. For the six months ended June 30, 2025, the Company reported earnings of $6.5 million and earnings per diluted share of $0.65 compared to the prior year period of $7.8 million and earnings per diluted share of $0.75. The Company’s second quarter 2025 operating results reflected the following changes from the...

Continue reading

New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox

Ongoing mpox outbreak continues to be a global health threat and is driving need for greater therapeutic research and innovation GAITHERSBURG, Md., July 28, 2025 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announced the publication of a comprehensive review article, “Brincidofovir in the Era of Mpox,” in the peer-reviewed journal Expert Review of Anti-infective Therapy.1 This publication includes an overview of brincidofovir, in vitro and in vivo data, including human case studies of the investigational use of brincidofovir, the current evaluation for treating mpox infections in adults and pediatrics in the Democratic Republic of Congo, and the potential for combination therapy with tecovirimat for immunocompromised patients with severe disease.     “We believe in the importance of assessing brincidofovir,...

Continue reading

Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives

GAITHERSBURG, Md., July 28, 2025 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announces its recognition of the U.S. House of Representatives for adding over-the-counter (OTC) naloxone to every AED location in its buildings, providing direct access to first responders and anyone coming across an individual who may be experiencing an opioid overdose. This effort has been led by Representative Buddy Carter (R-GA), with his team and congressional constituents, who have kept this public health issue a priority. Expanding access to potentially life-saving treatments is critical to saving more Americans and their families from an opioid overdose death. Emergent remains focused on saving lives through efforts to increase access, awareness and the availability of NARCAN® Nasal Spray 4 mg and KLOXXADO® Nasal Spray 8 mg....

Continue reading

Inception Growth Acquisition Limited Announces Adjournment of the Special Meeting to August 8, 2025 and Extension of Redemption Deadline

New York, July 28, 2025 (GLOBE NEWSWIRE) — On July 25, 2025, Inception Growth Acquisition Limited (the “Company”), a blank check company, previously announced that it convened its special meeting (“Special Meeting”) and immediately adjourned the Special Meeting, without conducting any business, to August 8, 2025. The Special Meeting was adjourned as to all of the proposals contained in the Company’s definitive proxy statement filed with the Securities and Exchange Commission (“SEC”) on May 27, 2025, as supplemented by the supplement to the definitive proxy statement on June 26, 2025 (the “Proxy Statement”), including the proposal to approve the proposed business combination with AgileAlgo Holdings Ltd. Redemption Deadline Extended The Company would like to further clarify that as a result of the adjournment, the deadline for delivery...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.